These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 23984926)

  • 1. Gene therapy for heart disease: molecular targets, vectors and modes of delivery to myocardium.
    Scimia MC; Cannavo A; Koch WJ
    Expert Rev Cardiovasc Ther; 2013 Aug; 11(8):999-1013. PubMed ID: 23984926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potential of genes in cardiac repair.
    Pal SN; Kofidis T
    Expert Rev Cardiovasc Ther; 2013 Aug; 11(8):1015-28. PubMed ID: 23945013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent developments and perspectives on gene therapy using synthetic vectors.
    Schlenk F; Grund S; Fischer D
    Ther Deliv; 2013 Jan; 4(1):95-113. PubMed ID: 23323783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evolution of heart gene delivery vectors.
    Wasala NB; Shin JH; Duan D
    J Gene Med; 2011 Oct; 13(10):557-65. PubMed ID: 21837689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methods to improve cardiac gene therapy expression.
    Scimia MC; Sydnes KE; Zuppo DA; Koch WJ
    Expert Rev Cardiovasc Ther; 2014 Nov; 12(11):1317-26. PubMed ID: 25340284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herpes simplex virus-based vectors.
    Lachmann R
    Int J Exp Pathol; 2004 Oct; 85(4):177-90. PubMed ID: 15312123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the heart with gene therapy-optimized gene delivery methods.
    Müller OJ; Katus HA; Bekeredjian R
    Cardiovasc Res; 2007 Feb; 73(3):453-62. PubMed ID: 17097076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy to regenerate heart muscle.
    Harv Heart Lett; 2014 May; 24(9):8. PubMed ID: 25151673
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiac gene therapy in large animals: bridge from bench to bedside.
    Ishikawa K; Tilemann L; Ladage D; Aguero J; Leonardson L; Fish K; Kawase Y
    Gene Ther; 2012 Jun; 19(6):670-7. PubMed ID: 22301438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous methods of vector delivery in preclinical models.
    Ladage D; Ishikawa K; Tilemann L; Müller-Ehmsen J; Kawase Y
    Gene Ther; 2012 Jun; 19(6):637-41. PubMed ID: 22418064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The road ahead: working towards effective clinical translation of myocardial gene therapies.
    Katz MG; Fargnoli AS; Williams RD; Bridges CR
    Ther Deliv; 2014 Jan; 5(1):39-51. PubMed ID: 24341816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac gene therapy: Recent advances and future directions.
    Mason D; Chen YZ; Krishnan HV; Sant S
    J Control Release; 2015 Oct; 215():101-11. PubMed ID: 26254712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene transfer to neurons using herpes simplex virus-based vectors.
    Fink DJ; DeLuca NA; Goins WF; Glorioso JC
    Annu Rev Neurosci; 1996; 19():265-87. PubMed ID: 8833444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy: twenty-first century medicine.
    Verma IM; Weitzman MD
    Annu Rev Biochem; 2005; 74():711-38. PubMed ID: 15952901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adeno-associated virus vector delivery to the heart.
    Bish LT; Sweeney HL; Müller OJ; Bekeredjian R
    Methods Mol Biol; 2011; 807():219-37. PubMed ID: 22034032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy for primary immunodeficiencies.
    Kildebeck E; Checketts J; Porteus M
    Curr Opin Pediatr; 2012 Dec; 24(6):731-8. PubMed ID: 23073463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted gene repair -- in the arena.
    Kmiec EB
    J Clin Invest; 2003 Sep; 112(5):632-6. PubMed ID: 12952907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleic acid-based modulation of cardiac gene expression for the treatment of cardiac diseases. Approaches and perspectives.
    Poller W; Fechner H; Kurreck J; Pauschinger M; Kühl U; Erdmann VA; Lamers JM; Schultheiss HP
    Z Kardiol; 2004 Mar; 93(3):171-93. PubMed ID: 15024585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine aspects of cancer gene therapy.
    Barzon L; Boscaro M; Palù G
    Endocr Rev; 2004 Feb; 25(1):1-44. PubMed ID: 14769826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adeno-associated virus and lentivirus pseudotypes for lung-directed gene therapy.
    Wilson JM
    Proc Am Thorac Soc; 2004; 1(4):309-14. PubMed ID: 16113451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.